Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma

Carcinogenesis

Volumn 37, Issue 4, 2015, Pages 356-365

  Krause, Lutz ^a,b   Nones, Katia ^a,b   Loffler, Kelly A ^a   Nancarrow, Derek ^b   Oey, Harald ^a   Tang, Yue Hang ^a   Wayte, Nicola J ^a   Patch, Ann Marie ^a,b   Patel, Kalpana ^a,c   Brosda, Sandra ^a,d   Manning, Suzanne ^a   Lampe, Guy ^e   Clouston, Andrew ^a   Thomas, Janine ^e   Stoye, Jens ^d   Hussey, Damian J ^f   Watson, David I ^f   Lord, Reginald V ^g,h,i   Phillips, Wayne A ^j,k   Gotley, David ^a   Mark Smithers, B ^a   Whiteman, David C ^b   Hayward, Nicholas K ^b   Grimmond, Sean M ^a,l   Waddell, Nicola ^a,b   Barbour, Andrew P ^a   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d BIELEFELD UNIVERSITY   (Germany)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f FLINDERS UNIVERSITY   (Australia)

^g Lowy Packer Building   (Australia)

^h UNIVERSITY OF NOTRE DAME   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j PETER MACCALLUM CANCER CENTRE   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR; TUMOR MARKER;

ARTICLE; BARRETT ESOPHAGUS; BINDING SITE; CARCINOGENESIS; CELL ADHESION; CENTROMERE; CHROMOSOME SEGREGATION; CLINICAL FEATURE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CPG ISLAND; CPG ISLAND METHYLATOR PHENOTYPE; DNA METHYLATION; ESOPHAGEAL ADENOCARCINOMA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MARKER GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; STOMACH ADENOCARCINOMA; TRANSCRIPTION INITIATION SITE; WNT SIGNALING PATHWAY; ADENOCARCINOMA; ESOPHAGUS TUMOR; GENETICS; PATHOLOGY; SPINDLE APPARATUS;

ADENOCARCINOMA; CHROMOSOME SEGREGATION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; HUMANS; SPINDLE APPARATUS;

EID: 84963554000     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgw018     Document Type: Article

References (51)

1. Dulak, A.M. et al. (2013) Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet., 45, 478-486.
2. Jemal, A. et al. (2010) Cancer statistics, 2010. CA Cancer J. Clin., 60, 277-300.
3. Cook, M.B. et al. (2007) Risk of mortality and cancer incidence in Barrett's esophagus. Cancer Epidemiol. Biomark. Prev., 16, 2090-2096.
4. Weaver, J.M. et al. (2014) Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat. Genet., 46, 837-843.
5. Alexandrov, L.B. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415-421.
6. Nones, K. et al. (2014) Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat. Commun., 5, 5224.
7. Laird, P.W. (2003) The power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3, 253-266.
8. Jones, P.A. et al. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
9. Xu, E. et al. (2013) Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis, 34, 2750-2756.
10. Alvarez, H. et al. (2011) Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet., 7, e1001356.
11. Kaz, A.M. et al. (2011) DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses. Epigenetics, 6, 1403-1412.
12. Smith, E. et al. (2008) Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Mol. Cancer, 7, 75.
13. Ott, P.A. et al. (2014) Vaccines and melanoma. Hematol. Oncol. Clin. North Am., 28, 559-569.
14. Pidsley, R. et al. (2013) A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics, 14, 293.
15. Naeem, H. et al. (2014) Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics, 15, 51.
16. Chen, Y.A. et al. (2013) Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics, 8, 203-209.
17. Du, P. et al. (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics, 24, 1547-1548.
18. Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202-209.
19. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
20. Aryee, M.J. et al. (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics, 30, 1363-1369.
21. Zouridis, H. et al. (2012) Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci. Transl. Med., 4, 156ra140.
22. Weisenberger, D.J. et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet., 38, 787-793.
23. Hinoue, T. et al. (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res., 22, 271-282.
24. Consortium, E.P. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
25. Rosenbloom, K.R. et al. (2013) ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res., 41, D56-D63.
26. Lawrence, M. et al. (2009) rtracklayer: an R package for interfacing with genome browsers. Bioinformatics, 25, 1841-1842.
27. Eads, C.A. et al. (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res., 60, 5021-5026.
28. Clément, G. et al. (2006) Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J. Pathol., 208, 100-107.
29. Tischoff, I. et al. (2007) Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut, 56, 1047-1053.
30. Peng, D.F. et al. (2009) DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut, 58, 5-15.
31. Jin, Z. et al. (2008) Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression. Cancer Epidemiol. Biomark. Prev., 17, 111-117.
32. Jin, Z. et al. (2008) Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer, 112, 43-49.
33. Jin, Z. et al. (2007) Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene, 26, 6332-6340.
34. Jin, Z. et al. (2007) Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer. Clin. Cancer Res., 13, 6293-6300.
35. Brock, M.V. et al. (2003) Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin. Cancer Res., 9, 2912-2919.
36. Moinova, H. et al. (2012) Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies. Cancer Epidemiol. Biomark. Prev., 21, 594-600.
37. Zou, H. et al. (2005) Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int. J. Cancer, 116, 584-591.
38. Nones, K. et al. (2014) Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLITROBO, ITGA2 and MET signaling. Int. J. Cancer, 135, 1110-1118.
39. Thiele, C.J. et al. (2009) On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin. Cancer Res., 15, 5962-5967.
40. Guo, M. et al. (2015) CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in nonsmall cell lung cancer. Discov. Med., 19, 151-158.
41. Soutto, M. et al. (2010) Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas. Cancer, 116, 4033-4042.
42. Wang, M. et al. (2014) Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer. Med. Oncol., 31, 907.
43. Stolz, A. et al. (2015) Wnt-mediated protein stabilization ensures proper mitotic microtubule assembly and chromosome segregation. EMBO Rep., 16, 490-499.
44. Vitale, I. et al. (2011) Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell Biol., 12, 385-392.
45. Weaver, B.A. et al. (2006) Does aneuploidy cause cancer? Curr. Opin. Cell Biol., 18, 658-667.
46. Maley, C.C. et al. (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet., 38, 468-473.
47. Davison, J.M. et al. (2014) The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma. PLoS One, 9, e79079.
48. Bharadwaj, R. et al. (2004) The spindle checkpoint, aneuploidy, and cancer. Oncogene, 23, 2016-2027.
49. Duijf, P.H. et al. (2013) The cancer biology of whole-chromosome instability. Oncogene, 32, 4727-4736.
50. Gal-Yam, E.N. et al. (2008) Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl Acad. Sci. USA, 105, 12979-12984.
51. Noushmehr, H. et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell, 17, 510-522.